RxDoctor Payments Data

Stephen McCann, APRN

Psychiatric/Mental Health · Middletown, DENPI 1528605912

Payments from drug & device makers

$1,355in general payments, 2019–2025

Across 85 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$441
  • Scilex Pharmaceuticals Inc.$203
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$145
  • AbbVie$62
  • Nevro Corp.$61
  • IBSA Pharma Inc.$56
  • plus $387 from 12 others

What the payments were for

  • Food & beverage$1,355100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,355 in reported general payments places this provider in the 65th percentile of 177 psychiatric/mental health providers in Delaware.

See all psychiatric/mental health providers in Delaware

Medicare billing

Part B allowed, 2024
$27,959
Medicare patients
73
Services billed
753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl75$86,789
Xtampza ErOxycodone Myristate129$86,480
BelbucaBuprenorphine Hcl20$18,851
Oxycodone Hcl826$18,810
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen478$15,155
Nucynta ErTapentadol Hcl12$13,007
Buprenorphine43$12,723
ZtlidoLidocaine15$11,418
Tramadol Hcl ErTramadol Hcl88$6,427
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen235$6,332
Morphine Sulfate ErMorphine Sulfate198$5,817
MovantikNaloxegol Oxalate11$4,360
Gabapentin270$4,204
Cyclobenzaprine Hcl120$3,004
Lidocaine32$2,449

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er$441$118,338161 claims
Scilex Pharmaceuticals Inc.Ztlido$203$11,41815 claims
Redhill Biopharma Inc.Movantik$32$4,36011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 177 psychiatric/mental health providers in Delaware.

Other psychiatric/mental health in Middletown

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →